Humira

Active substance

Adalimumab

Holder

AbbVie

Statut

Closed

Indication

Treatment of paediatric chronic non-infectious anterior uveitis patients (from 2 years of age) who have had an inadequate response to conventional therapy including topical corticosteroid and an immunomodulator, or who are intolerant to or have contraindications for such therapies

Documents publics

Approbation

Information for the patient

Informed consent

Last update

04/12/2018

Last updated on 13/02/2024